The Malaysian government has continuously strived to improve and expand its clinical research ecosystem for the past ten years. The primary goal is to provide a competitive landscape with internationally recognised clinical trial hubs as more pharmaceutical companies continue shifting their clinical trial bases to Asia. Nur Ain Amir, Cheng Shu Hui and Audrey Ooi at Clinical Research Malaysia focus on the current status of Malaysian investigators and the future perspectives for CRM and the MoH in growing the country’s clinical investigators pool.